• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
The Neurotechnology Industry 2013 Report - Product Image

The Neurotechnology Industry 2013 Report

  • Published: August 2013
  • Region: Global
  • 612 Pages
  • NeuroInsights

FEATURED COMPANIES

  • 23andMe
  • BioDirection
  • Elekta
  • Meda
  • NsGene
  • Sarepta
  • MORE

Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System: Market Analysis and Strategic Investment Guide of the Global Neurological Disease and Psychiatric Illness Markets

Now in its ninth year, The Neurotechnology Industry 2013 Report is an expanded and updated 600 page report of brain and nervous system markets and treatments. It is the only publication to provide a comprehensive pipeline and market analysis to help investors, companies and entrepreneurs easily identify opportunities, understand the competitive landscape, determine risks and understand the dynamics of rapidly changing CNS markets.

The report includes detailed information on products in development globally for over 18 indications at 800 companies including Alzheimer's, addiction, ALS, anxiety, depressive disorders, epilepsy, migraine, mild cognitive impairment, Huntington's, multiple sclerosis, obesity, pain, Parkinson's, schizophrenia, age-related macular degeneration, sensory disorders, sleep disorders, traumatic brain injury and stroke.

Report Highlights

The Neurotechnology Industry 2013 Report provides a unified market-based framework to help executives, READ MORE >

1: Executive Summary

The Brain Industry Revealed
- Neuropharmaceuticals
- Cell Therapies
- Neurodevices
- Neurodiagnostics

Investment Risks and Opportunities
- Translating Neuroscience into Neurotech
- The Neurotech Market Opportunity

Key Industry Facts and Findings

2: Trends and Drivers

Converging Technology Drivers
- Crossing the Blood Brain Barrier

Demographic Drivers
- More People Living Longer
Social Drivers
- The Lifestyle Improvement Market

Economic Drivers
- Global Economic Burden of Brain-Related Illness
- Rising Health Care Costs

Research Funding
- US Government Research Funding
- Stem Cell Funding
- International Government Research Funding
- Foundations Focus on the Brain

Intellectual Property Trends
- Global Intellectual Property Protection
- Patent Expirations

Neurotech Merger and Acquisition Activity (2005-Q12013)

3: Neuropharmaceutical Sector

Neuropharmaceutical Sector Overview
- Trends in Neuropharmaceuticals
- Big Pharma Scales Back
- Treatments in Development and Abandoned by Indication 2006-2012

Neuropharmaceutical Partnering and Licensing
- Partnering and Licensing Personnel
- Partnering and Licensing Deals 2004-Q12013
- Neurology Markets and Pipelines
- Alzheimer's Disease (AD)
- AAMI and MCI
- Epilepsy and Seizure Disorders
- Huntington's disease
- Migraine
- Multiple Sclerosis
- Parkinson's Disease
- Sleep Disorders
- Restless Legs Syndrome
- Stroke
- Traumatic Brain Injury

Psychiatry Markets and Pipelines
- Addiction
- Anxiety Disorders
- Attention Disorders
- Depressive Disorders
- Bipolar Disorder
- Obesity
- Schizophrenia
- Cognitive Impairment Associated with Schizophrenia

Sensory Markets and Pipelines
- Pain
- Retinal Disorders

4: Stem Cells and Neuroregeneration

Defining Stem Cell Markets and Players
- Therapeutics
- Drug Discovery Tools
- Stem Cell Banking

Stem Cell Approaches
- Background
- The Science of Transplantion
- Controlling Immune Rejection and Infection
- Sources and Harvesting of Stem Cells
- Embronic Stem Cells
- Fetal Stem Cells
- Adult Stem Cells
- Stimulation of Endogenous Stem Cells
- Stem Cells Scientific Hurdles

Markets and Treatments in Development
- Alzheimer's Disease
- Amyotrophic Lateral Sclerosis (ALS)
- Hearing Loss
- Huntington's Disease (HD)
- Multiple Sclerosis (MS)
- Parkinson's Disease
- Retinal Disorders
- Spinal Cord Injury (SCI)
- Stroke
- Other CNS Diseases

5: Neurodevice Sector

Neurodevice Sector Overview
- Neurodevice Markets
- Regulatory Process in the US
- Regulatory Process in the EU
- Neurodevice Sector Trends
- Investment by Major Device companies
- Neurodevice M&A Activity (2005-Q12013)

Neuroprosthetic Devices
- Cochlear Implants
- Retinal Implants
- Motor Prostheses and Brain Computer Interfaces

Neuromodulation Devices
- Neuromodulation Device Clinial Trials and Recent Approvals
- Deep Brain Stimulation
- Essential Tremor
- Parkinson's Disease
- Primary Dystonia
- Severe Obsessive Compulsive Disorder
- Treatment-Resistant Depression
- Epilepsy
- Traumatic Brain Injury and Stroke
- Transcranial Magnetic Stimulation (TMS)
- Alzheimer's
- Treatment Resistant Depression
- Migraine
- Transcranial Electrical Stimulation (TES)
- Transcranial Direct Current Stimulation (tDCS)
- Transcranial Alternating Current Stimulation (tACS)
- Transcranial Random Noise Stimulation (tRNS)
- Focused Ultrasonic Modulation
- Spinal Cord Stimulation (SCS)
- Chronic and Neuropathic Pain
- Spinal Cord Injury
- Vagus Nerve Stimulation (VNS)
- Epilepsy
- Treatment-Resistant Depression
- Obesity
- Peripheral Stimulation
- Assisted Breathing
- Epilepsy
- Fecal Incontinence
- Foot Drop
- Hypertension
- Migraine
- Neuropathic Pain
- Restless Legs Syndrome
- Sleep Apnea
- Stroke
- Urinary Conditions
- Gastric Modulation and Obesity

Neurosurgical devices
- Radiosurgical Devices
- Neurosurgical Navigation and Equipment
- Image Guided Navigation (IGN)
- Intraoperative Magnetic Resonance Imaging (iMRI)
- Automated Surgical Systems
- Brain Monitoring
- Temperature Control Systems
- Neurovascular Intervention
- Ischemic Stroke
- Catheters, Stents and Perfusion devices
- Retrieval and Protection devices
- Ultrasound Thrombolysis
- Hemorrhagic Stroke
- Coils
- Liquid Embolics
- Stents

Neurosoftware
- Attention Deficit Disorder
- Cognition and Aging
- Stress and Emotional Wellbeing
- Autism
- Addiction and Obesity
- Pain
- Schizophrenia

Therapeutic NeuroGaming

6: Neurodiagnostics Sector

Neurodiagnostic Sector Overview
- FDA Approval and Reimbursement of Diagnostics

Neuroimaging Technologies
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Nuclear Medicine Imaging (PET, SPECT)
- Electro-encephalography (EEG)
- Magneto-encephalography (MEG)

In Vitro Diagnostics
- In Vitro Diagnostics Regulatory Landscape
- Emerging Diagnostics for Alzheimer's Disease
- Emerging Diagnostics for TBI
- Genetic Testing and Pharmacogenomics
- Protein Biomarker Assays
- Pattern Recognition in Diagnostics
- Emerging Diagnostics for Psychiatry
- Emerging Diagnostics for Autism

Neuroinformatics
- Diagnostic Software

7: Private Neurotechnology Investment

Private Investment in Neurotechnology
- Venture Capital Investment Trends
- Neurotech Venture Capital Investment
- Investing in Neuropharmaceuticals
- Investing in Stem Cells and Neuroregeneration
- Investing in Neurodevices
- Investing in Neurodiagnostics
- Private Company Financings, 2012
- Top financings 2004-2012
- Leading Neurotech Investors
- Leading Venture Capital Firms

8: Public Neurotechnology Investment

Investing in Public Neurotech Companies
- Neurotech Stock Universe

Neurotech Initial Public Offerings

NeuroInsights Neurotech Index

9: Neurotechnology Research Centers

Leading Neurotechnology Research Centers
- University of California, San Francisco (UCSF)
- University of California, Los Angeles (UCLA)
- University of California, San Diego (UCSD)
- Harvard
- Stanford University
- Massachusetts Institute of Technology (MIT)
- Columbia University
- Washington University, St. Louis
- University College London (UCL)
- Karolinska Institutet, Stockholm
- RIKEN Brain Science Institute, Japan

Places to Watch
- National Brain Research Centre (NBRC), India
- Neurosciences Victoria, Australia (NSV)
- Univeristy of Helsinki, Finland

10: Leading Neurotechnology Regions

The Global Neurotech Economy

Nexus Ranking and Methodology

Established Neurotech Nexus'

Emerging Neurotech Nexus'

Nascent Neurotech Nexus'

Conclusions and Policy Recommendations

11: Company Profiles

Neuropharmaceutical & Cell Therapy Companies: Private

Neuropharmaceutical & Cell Therapy Companies: Public

Neurodevice Companies: Private

Neurodevice Companies: Public

Neurodiagnostic Companies: Private

Neurodiagnostic Companies: Public

12: Index

The Neurotechnology Industry 2013 Report: Exhibits, Tables, and Charts

1-1: Number of Individuals Afflicted by Indication, US and Worldwide, Top 15 Indications
1-2: Global Pharmaceutical Sales by Indication, 2012
1-3: Neurotechnology Industry Taxonomy
1-4: Proportion of Patient Population Segmented by Neurotech Market Opportunity
1-5: NASDAQ NeuroInsights Neurotech Index Performance vs. S&P500, NASQAQ Composite, and NASDAQ Biotechnology Index
2-1: Projected Percentage Increase in Global Populations aged 65 and over, 1994-2020
2-2: Neuropharmaceutical Patent Expirations and Generic Competition, 2003-2020
2-3: Selected US Foundations with a Significant focus on Brain Research and Education
2-4: Most Generous Philanthropists for Medical and Brain Research
2-5: Neurotech M&A Activity (2004-Q12013)
3-1: Neuropharmaceutical Revenues, Growth Rate by Indication (2012)
3-2: FDA Pharmaceutical Approval Process
3-3: Products Abandoned and Approved by Indications (2006-2013)
3-4: Neuropharmaceutical Partnering and Licensing Deals (2004-Q1 2013)
3-5: WW Revenue of Top Alzheimer's Drugs (2006-2012)
3-6 Clinical Trials for Alzheimer's disease (company, compound, phase, mechanism)
3-7: Clinical Trials for AAMI and MCI (company, compound, phase, mechanism)
3-8: WW Revenue of Top Antiepileptics (2006-2012)
3-9: Clinical Trials for Epilepsy (company, compound, phase, mechanism)
3-10: Clinical Trials for Huntington's disease (company, compound, phase, mechanism)
3-11: WW Revenue of Top Migraine Agents(2006-2012)
3-12: Clinical Trials for Migraine (company, compound, phase, mechanism)
3-13: Clinical Trials for Multiple sclerosis (company, compound, phase, mechanism)
3-14: WW Revenue of Top Anti-Parkinson's Agents (2006-2012)
3-15: Clinical Trials for Parkinson's disease (company, compound, phase, mechanism)
3-16: Clinical Trials for sleep disorders (company, compound, phase, mechanism)
3-17: Clinical Trials for stroke Treatment (company, compound, phase, mechanism)
3-18: Clinical Trials for Traumatic Brian Injury (company, compound, phase, mechanism)
3-19: Number of People with Addiction and Impulse Control Disorders (WW and US)
3-20: Clinical Trials for Addition and Substance abuse (company, compound, phase, mechanism)
3-21: Clinical Trials for Snxiety Disorders (company, compound, phase, mechanism)
3-22: WW Revenue of Top ADHD Drugs (2006-2012)
3-23: Clinical Trials for ADHD (company, compound, phase, mechanism)
3-24: WW Revenue of Top Antidepressants (2006-2012)
3-25: Clinical Trials for Depressive disorders (company, compound, phase, mechanism)
3-26: Clinical Trials for Obesity Treatment (company, compound, phase, mechanism)
3-27: Clinical Trials for Schizophrenia and Psychosis (company, compound, phase, mechanism)
3-28: WW Revenue of Top Antipsychotics (2006-2012)
3-29: Clinical Trials for Retinal disorders (company, compound, phase, mechanism)
3-30: Clinical Trials for Nociceptive Pain (company, compound, phase, mechanism)
3-31: Clinical Trials for Neuropathic Pain (company, compound, phase, mechanism)
4-1: Neurodevice Markets and Revenues (Neuroprosthetic, Neuromodulation, Neurosurgical, Neurofeedback)
4-2: Neurodevice Investment Activity: Medtronic, Boston Scientific, J&J
4-3: Neurodevice M&A Activity (2004-Q12013)
4-4: Neuromodulation Device Clinical Trials
5-1: Neurodiagnostics Markets and Annual Growth (Neuroimaging, In Vitro Diagnostics, Neuroinformatics)
5-2: FDA Approval and Insurance Reimbursement of Diagnostics
5-3: Neuroimaging Technology (CT, MRI, fMRI, PET, SPECT, EEG, MEG)
5-4: Alzheimer's Disease Neuroimaging Initiative
5-5: Neuroinformatics Data Storage
5-6: Paul Allen Brain Atlas Project and IBM Blue Brain Project
6-1: Total Venture Capital Investment, 1999-2012
6-2: Life Science Venture Capital Investment, 1999-2012
6-3: Neurotechnology Venture Capital Investment, 1999-2012
6-4: Neurotech as Percent of Life Science Venture Investment, 1999-2012
6-5: Top Five Neurotechnology Venture Capital Financings, 2001-2012
6-6: Top 110 Investors in Neurotech
6-7: Top 11 Neurotech Venture Capital Firms with Investments
7-1: Neurotechnology Initial Public Offerings US, 2004-Q2 2013
7-2: Neurotech Stock Universe Fundamentals 2012
7-3: Neurotech Index Performance Vs. S&P 500 and NASDAQ Biotech Index
8-1 Leading Neurotechnology Research Centers
8-2 Neurotech Research Centers and Affiliated Institutes, Funding, Recent Significant Investments, Reputation, Translation of Discoveries to Industry
8-3: UCSF
8-4: UCLA
8-5: Harvard University
8-6: Stanford University
8-7: MIT
8-8: Columbia University
8-9: Washington University
8-10: University College London
8-11: Karolinska Institute
8-12: RIKEN Brain Science Institute
9-1 NeuroInsights' Leading Neurotech Nexus Ratings
9-2 Conclusions and Policy Recommendations
10-1 Neuropharmaceutical Companies Private Profiles (status, funding, location, investment, descriptions, investors)
10-2 Neuropharmaceutical Companies Public Profiles (status, symbol, HQ, market cap revenues, description)
10-3 Neurodevice Companies Private Profiles (status, funding, location, investment, descriptions, investors)
10-4 Neurodevice Companies Public Profiles (status, symbol, HQ, market cap revenues, description)
10-5 Neurodiagnostic Companies Private Profiles (status, funding, location, investment, descriptions, investors)
10-6 Neurodiagnostic Companies Public Profiles (status, symbol, HQ, market cap revenues, description)

23andMe
454 Life Sciences
7TM Pharmaceuticals

A

AbaStar MDx
Abbott
Abbvie
Abela Pharmaceuticals
Abiogen
AB Science
ABT Molecular Imaging
Acadia Pharmaceuticals
Accera
AccSys Technology
Accuray
AcelRx
AC Immune
Acorda
Actelion
Active Biotech
Acucela
Acumen Pharmaceuticals
Acura
Adamas
Addex Therapeutics
Adenios
Adenosine Therapeutics
Adeona
ADial
Adlyfe
Adolor
advanceCor
Advanced Bionics
Advanced Brain Monitoring
Advanced Brain Technologies
Advanced Cell Technology
ADx Neurosciences
Aeolus
Aestus Therapeutics
Affectis
Afferent Pharmaceuticals
AFFiRiS
Affiris
Affymetrix
Afraxis
Agenebio
Akili Interactive Labs
Alcobra
Alcon
Alder Biopharma
Aleva Neurotherapeutics
Alexion
Alexza
Algos Therapeutics
AlgoStim
Alimera
Alinea
Alkermes
Allen Institute for Brain Science
Allergan
Allivia Health
AllTranz Pharmaceuticals
Alnylam
Alpha Omega Engineering
Alpharma
ALS Biopharma
Alseres
Alsius
Alzhyme
Amarantus
Ambrose Pharmaceuticals
Ambrx
Ameritox
Amersham
Amgen
Amicus
Amkor
Amnestix
Amplimmune
Amsterdam Molecular
Anavex
Anesiva
AngioChem
Aniona
ANM Adaptive
Annexon
Antisense Therapeutics
ANT Neuro
Anylam
Apitope
Apnex Medical
Applied NeuroSolutions
Aptalis
Aranthus Therapeutics
Archer Pharma
Archimedes
ARCH Venture Partners
Arcion
Ardian
Arena Pharmaceuticals
Aria Neurosciences
ArmaGen
Arrien Pharmaceuticals
Arteaus
Artielle
ArunA
Asceneuron
Asklepios
Aspect Medical
Aspreva
Assurex Health
Astellas
Astex
Astraea
AstraZeneca
Astro-Med
AsuraGen
Athena Diagnostics
Athersys
AurimMed Pharma
Auris Medical
Autifony
Autonomic Technologies
Avanir
Avicena
Avid Radiopharmaceuticals
Avigen
AviNeuro
Avraham Pharmaceuticals
Axerion Therapeutics
AxoGen
Axon Neuroscience
Axxam
Axxonis
Azevan
Azur Pharmaceuticals

B

Banyan Biomarkers
Barofold
BAROnova
BaroSense
Baxter
Bayer
Bayhill Therapeutics
Bedford Stem Cell Research Foundation
Beike
BeneChill
BHR Pharma
BIAL
Biodelivery Sciences
BioLineRx
Bioalvo
BioArctic
Bioasis
BioAxone
BioBehavioral Diagnostics
BioControl Systems
Biocortech
Biocrea
Biodesy
BioDirection
BioFocus
Biofrontera
Biogen Idec
BioLineRx
Biomarin
Bioness
Bionic Vision Australia
Bionomics
BioRad
Biota
Biotie
Biovitrum
Blackrock Microsystems
Bluebird bio
Blue Marble Game Company
Boehringer Ingelheim
Boston Scientific
Bracco Diagnostics
Braeburn Pharmaceuticals
BrainCells
BrainLAB
Brain Plasticity Insitute
Brain Resource
BrainScope
BrainsGate
BrainSonix
BrainStorm Cell Therapeutics
Brainsway
BrainTrain
BrainZ
Bristol-Myers Squibb
Britannia
BTG International
Buck Institute for Age Research
BW Safari

C

Cadence
Cadwell Laboratories
California Stem Cell
Cambridge Cognition
Canbex
Capnia
Cara Therapeutics
Cardium Therapeutics
CareFusion
Carlsson Research
Carrot Neurotechnology
Catalina Imaging
Catalyst Pharma
CCC Medical Devices
CDHI
Celentyx
Cell Cure Neurosciences
CellMed
Cell Therapeutics
Cellzome
Celtic
Celvive
Centocor
Cerbomed
Cerecor
Ceregene
Cerenaic
Cerephex
Cerimon
Cervel Neurotech
Chaperone Therapeutics
Chase Pharmaceuticals
CHDI Foundation
Checkpoint Surgical
Chelsea Therapeutics
Chestnut
Chiesi
Chondrogene
Chugai
CIRTEC Medical
Civitas
Clarus Medical
Clera
Cleveland Clinic
Cleveland Medical Devices
Clinical Data
CNS Response
CNS Vital Signs
CoAxia
Cochlear Ltd.
Coco Therapeutics
Codman
Cogmed
CogniFit
Cognition Therapeutics
Cognitive Drug Research
Cognitive Pharma
Cognoptix
Cognosci
CogState
CoLucid
Combimatrix
CombinatoRx
CoMentis
Compellis
Compumedics
Concentric Medical
Concert Pharmaceuticals
Concit Pharma
Convergence Pharma
CoolSpine
Corcept Therapeutics
Cortech
Cortex
Covidien
CPS Innovations
CTI Molecular Imaging
Cubist
Curidium
CVRx
CyberLearning
Cyberonics
CyDex Pharma
Cynapsus
Cyrenaic Pharmaceuticals
Cytogel
Cytomedix
Cytos
Cytox

D

Deep Brain Innovations
D-Pharm
Daiichi Sankyo
Dainippon
Dakim
Dara Bioscience
Dart Neuroscience
DaVinci Biosciences
Debiopharm
DeCODE Genetics
Depomed
DiaGenic
Dianippon
DNATraits
Domain Therapeutics
Douglas Pharmaceuticals
Durect
Durin Technologies
Dynogen

E

EBS Technologies
Edgemont Pharmaceuticals
Edge Therapeutics
EEG Spectrum
Eisai
Elan
elbion
Elcelyx Therapeutics
Electrical Geodesics
ElectroCore
Elekta
Eli Lilly
Elixir
Ellipsis
ElMinda
Embera
Emisphere
EMKinetics
Emotiv Systems
EncephRx
Endo Pharmaceuticals
EndoSphere
Endostim
eNeura
Enkam Pharmaceuticals
eNOS
Enpath
Ensemble Discovery
EnteroMedics
EnVivo Pharmaceuticals
Envoy Medical
Envoy Therapeutics
Eos Neuroscience
Epalex
EpiCept
Epilepsy Therapy Project
Epix Pharmaceuticals
Ergoresearch
EStimME
e-therapeutics
Ethicon
Euthymics Bioscience
Evotec
ExonHit
Eyegate

F

Fabre-Kramer
Fast Forward
Faust
FineTech Medical
Fisher Wallace
FivePrime
Flowonix
Foc.us
Fonar
Forest
Fovea
Functional Neuromodulation

G

Galenea
Gedeon Richter
GE Healthcare
Gelesis
Genomind
Genosco
GeneNews
Genentech
Genesis Medical Imaging
GeNeuro
Genmab
GenVec
Genzyme
Geron
GI Dynamics
Gladstone Institute
GlaxoSmithKline
Glenmark
GoFlow
Greatbatch
Guilford Pharmaceuticals
GW Pharmaceuticals

H

Heptares Therapeutics
Hitachi Medical
H. Lundbeck
Hamilton Pharmaceuticals
Heidelberg Engineering
Helicon Therapeutics
Heptares
Hermo Pharma
Hitachi Medical
Horizon Pharma
Hospira
Hydra Biosciences

I

ICVRx
Imagine Neuro Solutions
Imagine Pharmaceuticals
ImaRx
Immune Response Biopharma
Impax
Impel Neuropharma
ImThera Medical
Incline Therapeutics
Ingenium
Innate Therapeutics
InnerCool Therapies
InSightec
InSound
Inspire Medical
Institute for the Study of Aging
Intec Pharma
Integra
Integragen
Intelect Medical
IntelGenX
Intelligent Medical Implants
Interaxon
International Stem Cell Corporation
Intific
Intra-Cellular Therapies
Intrapace
Invitrogen
InVivo Therapeutics
iPierian
Ipsen
Ironwood

J

Janssen
Jazz Pharmaceuticals
Jingxin Pharma
Johns Hopkins Brain Science Institute
Johnson & Johnson
Jordan Neuroscience

K

Kalypsys
Kappametrics
Karuna
Kempharm
Kitalpha Med
Knopp Neuro
Kosei
Kowa
Krenitsky Pharmaceuticals
Kyalin Biosciences
Kyowa

L

LabCorp
Labrys
LA MONT Medical
Lexicon
Lexicor Medical
Life Core Technologies
Ligand
Lineagen
Lotus
Luitpold
Lumosity
Lumos Labs
Lundbeck
Lungpacer

M

Mainstay Medical
Maas Biolab
MacuCLEAR
Madera
Magstim
Map Pharmaceuticals
Marco Polo
Marina Biotech
Marinus
MED-EL
Meda
MedAvante
Medesis
MedGenesis
MediciNova
Medistem
Meditor
MediVance
Medivation
Medpace
Medra
Medtrode
Medtronic
Meiji Seika
Merck
Merck Serono
Merlin MD
Merz
Mesoblast
Metabolon
MetaCure
Michael J. Fox Foundation
MicroTransponder
Microvention Terumo
Millipore
Mind-NRG
MindCare
Mindo
MindFrame
Mindguard
Mind Research Network
Mission Pharmacal
Mithridion
Mitsubishi
Mitsubishi Pharma
Mnemosyne Pharma
Mochida
Moeller Medical
Molecular Neuroimaging
Molecular Partners
Monteris Medical
Morphosys
MRC Systems
M's Science
Myomo
Myriad RBM

N

Nano Retina
Nanotherapeutics
Natus Medical
Naurex
Nautilus Neuroscience
Navidea
Navigenics
NBI Development
NDI Medical
Nektar
Neopraxis
NeoStim
NeoVista
Nervomatrix
Neural Signals
NeuralStem
Neuraltus
Neuralynx
Neuravi
NeurAxon
Neurelec
Neurelis
Neuren
Neurex
Neurim
Neurimmune
NeuroActive
Neuroadjuvants
Neuro Biomed
Neurocare
NeuroConn
Neurocrine
NeuroDerm
NeuroDiscovery
NeuroDx Development
Neurodyne
NeuroElectrics
Neurofit
NeuroFluidics
NeuroFocus
NeuroGeneration
NeuroGenetic Pharmaceuticals
Neurogenetics
NeuroGenomeX
NeuroHealing
Neuro Hi-Tech Pharmaceuticals
NeuroKin
Neuro Kinetics
NeuroKos
NeuroLink Medical
Neurolixis
Neurolutions
NeuroMetrix
NeuroMolecular Pharmaceuticals
NeuroNascent
Neuronax
Neuronetics
Neuronetrix
Neuronix
NeurOp
NeuroPace
NeuroPhage
NeuroPhysics
NeuroPore Therapies
NeuroProfile
Neuroptix
NeuroQuest
NeuroRepair
Neuros
Neuroscan
NeuroScience Pharmaceuticals
NeuroSearch
NeuroSigma
NeuroSky
Neuros Medical
NeuroSync
Neurotar
Neurotech Pharmaceuticals
Neurotech SA
Neurotez
NeuroTherapeutics Pharma
Neurotrack
NeuroTrax
NeuroTrek
NeuroTronik
Neurotune
NeuroVance
NeuroVasx
NeuroVigil
NeuroVista
NeuroVive
NeuroWave Systems
Nevro
Newron
Nexstim
NextWave
NFocus
Nihon Kohden
NimbleGen
Nippon Shinyaku
nLife Therapeutics
Nocacea
NoNo
Nordocs
Norgine
Novadel
Novartis
NovaVision
Noven
NovoNordisk
Novosis
NPS Pharmaceuticals
NsGene
Nuon Therapeutics
NuPathe
Nuron
Nymox

O

Obalon
Obecure
Olympus
Omeros
Omneuron
Ono Pharmaceuticals
Opexa
Ophthotech
OPKO
Optherion
Optima Neuroscience
OptiNose
Optobionics
OptumHealth
Ora Bio
Oraya
Orexigen
Orexo
Organon
Orion
Ornim
Orphan Medical
Ortho-McNeil
Oryx Pharmaceuticals
OSI Pharmaceuticals
Othera
OtoKinetics
Otonomy
Otsuka
Ottobock Healthcare
Ovation Pharmaceuticals
Oxford Biomedica
Oxford Instruments
Oxigene

P

P2D
Pacira
Pain Therapeutics
Paion
Paladin
Palatin
Paloma
Palyon
PanOptica
Pearson
Pediatric Bioscience
Penumbra
Penwest
Peptimmune
PeriphaGen
Pernix
Personal Neuro Devices
Pfizer
Phagenesis
Pharmacia
PharmaNess
PharmaNeuroBoost
PharmaPass
PharmatrophiX
Pharmaxon
PharmEste
Pharmos
Pharnext
Phase 2 Discovery
Pherin
Philips
PhotoThera
Physio-Control
PhysioSonics
Physonics
Phytopharm
Picker
Pierre Fabre
Plexon
Polaris Ventures
Posit
Positron Corporation
Posit Science
Pozen
Prana Biotech
Prexa Pharmaceuticals
Prexton Therapeutics
Pritzker Neuropsychiatric Disorders Research Consortium
Prize4Life
Probiodrug
ProEthic
Proneuron
Proreo
Prosensa
Prospex Medical
Protalix
Proteostasis
Proteosys
Proteotech
Prothena
Provid
Proximagen Neuroscience
pSividia
Psyadon
Psychogenics
Psynova
Pulsar Vascular
Purdue

Q

QiG Group
QR Pharma
QRxPharma
Q Therapeutics
Quark Pharmaceuticals
Quest
Questcor
Questor
QuickCool

R

Radiant Medical
Ranbaxy
Raptor Pharma
RaQualia
Reata Pharmaceuticals
Receptos
Reckitt Benckiser
RedHill Biopharma
Regeneron
Relievant
Relmada
Remedy Pharma
Remegenix
ReMYND
ReNeuron
Repligen
Reset Therapeutics
ReShape Medical
Rethink Autism
Retina Implant
Reverse Medical
Rexahn
Rhenovia
RhinoCyte
Rhythm Pharma
Ridge Diagnostics
Rinat
Roche
Rxi

S

Sage Therapeutics
Samsung
SanBio
Sanofi
Santhera
SantoSolve
Sapiens Brain Steering Stimulation
Sarentis Therapeutics
Sarepta
Satiety
Satoris
Schering-Plough
Schwarz
Scientific Brain Training
Scientific Learning
Seaside
Second Sight
Selecta Biosciences
Senexis
SeneXta
Senomyx
Sensory Medical
Sepracor
SeqWright
Servier
SetPoint Medical
Shimadzu Medical Systems
Shionogi
Shire
Siemens
Siena Biotech
Sigmedics
Signum Biosciences
Silere Medical
Simprota
Sinapis Pharma
Sirion
SK Biopharmaceuticals
SleepMed
SmartBrain Technologies
Solvay
Somanetics
Somerset Pharmaceuticals
Somnus
Sonexa
Sonova
Sorin Group
Sosei
Soterix Medical
Sound Pharmaceuticals
Spencer Technologies
Spherics
Spinal Modulation
SPR Therapeutics
St. Croix Medical
StemCells
St. Jude Medical
Stem Cells
Stem Cell Sciences
StemCell Technologies
Stem Cell Therapeutics
Stemedica
Stereotaxis
StimWave
Stryker
STX Medical
Summit
Sunovion
Supernus
SureGene
Suven
Sygnis
SynapDx
Synapse Biomedical
Synaptic Pharmaceutical
Synergia Pharma
Syngis
Synosia
Syntropharma

T

Taisho
Takeda
Tal Medical
Tanabe
Targacept
Targegen
Targeted Genetics
TauRx
TauTaTis
TCA Cellular Therapy
TeachTown
Temperon
TeraRecon
Teva
Theracos
TheraNova
Theravance
Thiakis
Tikvah
Titan Pharmaceuticals
toBBB
TONIX Pharma
Toshiba
Touch Bionics
Transcept
Transcription Diagnostics
Transition Therapeutics
Transneuronix
TransOral
TransTech
Trevena
Treventis
Trophos
Tucker-Davis

U

UCB
Ultragenyx
Unique Logic and Technology
Upsher Smith
US Worldmeds

V

Valeant
Validus
Vanda
Varian
Vasopharm
Vastox
Vela Pharmaceuticals
Velocimed
Vernalis
Victhom Human Bionics
Victory
Virobay
Visioncare
VisionCare Ophthalmic
Vistagen
Visualase
Vitae
Vivity Labs
Vivus
Vyteris

W

Wex Pharmaceuticals
Wicab
Wild Divine
Winston Pharma

X

Xanodyne
Xdynia
Xenome
Xenon
XenoPort
Xenova
Xention
Xigen
Xsira

Y

Yuma Therapeutics

Z

Zalicus
Zambon
Zenobia
Zinfandel
Zogenix
Zoll Medical
Zynex
ZZ Biotech

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos